Taylor Morrison (TMHC) Form 144 Notice — 21,967 Shares via Fidelity

Rhea-AI Filing Summary

Taylor Morrison Home Corporation (TMHC) filed a Form 144 notifying a proposed sale of 21,967 common shares through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,529,145.34. The filing lists the approximate date of sale as 08/22/2025. The shares to be sold were issued pursuant to stock options granted on 02/16/2021 (5,502 shares), 02/11/2022 (8,114 shares) and 02/21/2023 (8,351 shares), with cash payment indicated on the listed sale date. The filer reports no securities sold in the past three months and includes the statutory representation that they are not aware of undisclosed material adverse information about the issuer.

Positive

• Full disclosure of sale mechanics: broker, share count, aggregate market value and sale date are provided
• Securities sourced from option grants with specific grant dates and per-grant share quantities listed
• No securities sold in past three months is explicitly stated

Negative

• Filer relationship to issuer not specified in the provided tables
• No indication of a trading plan adoption date or further context for the sale beyond the Rule 144 notice

Insights

Securities Analyst

TL;DR: Routine insider/beneficial owner notice to sell ~21.97k shares (~$1.53M) via broker; no prior 3-month sales reported.

The Form 144 is a standard regulatory notice indicating the filer proposes to sell 21,967 common shares of TMHC through Fidelity on 08/22/2025, sourced from stock options granted in 2021–2023. The filing provides the broker, number of shares, aggregate market value and that payment will be cash. There is no disclosure here of the filer’s relationship to the issuer, nor of any material nonpublic information. This filing alone is procedural; it notifies the market of a planned sale but does not by itself indicate operational or financial changes at Taylor Morrison.

Corporate Governance Specialist

TL;DR: Compliance-focused disclosure of planned insider sale; appears consistent with Rule 144 procedural requirements.

The document lists required Rule 144 elements: class of security, broker, share count, aggregate value, outstanding shares and acquisition history tied to option grants. The filer affirms lack of undisclosed material adverse information and notes the anti-fraud warning. Absent here are details on the filer’s status (officer/director/affiliate) or any trading plan date. As presented, the filing meets notice purpose but yields limited governance implications without additional context.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21967	1529145.34	98843205	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Option Granted 02/16/2021	Issuer			5502	08/22/2025	Cash
Common	08/22/2025	Option Granted 02/11/2022	Issuer			8114	08/22/2025	Cash
Common	08/22/2025	Option Granted 02/21/2023	Issuer			8351	08/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is reported in the TMHC Form 144?

The filing reports a proposed sale of 21,967 common shares via Fidelity Brokerage with an aggregate market value of $1,529,145.34 and an approximate sale date of 08/22/2025.

How were the TMHC shares acquired by the filer?

The shares were acquired through stock options granted on 02/16/2021 (5,502 shares), 02/11/2022 (8,114 shares) and 02/21/2023 (8,351 shares).

Did the filer report any TMHC sales in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Which broker will handle the TMHC sale?

The sale is listed to be executed through Fidelity Brokerage Services LLC (900 Salem Street, Smithfield, RI).

Does the Form 144 assert the filer has undisclosed material information about TMHC?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.